BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15919445)

  • 41. Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough.
    Schrauder A; Saleh S; Sykora KW; Hoy H; Welte K; Boos J; Hempel G; Grigull L
    Pediatr Transplant; 2009 Jun; 13(4):444-50. PubMed ID: 18482216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
    J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial.
    Meier M; Nitschke M; Weidtmann B; Jabs WJ; Wong W; Suefke S; Steinhoff J; Fricke L
    Transplantation; 2006 Apr; 81(7):1035-40. PubMed ID: 16612281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY; Wong KM; Chan HW; Liu YL; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Li CS
    Transpl Int; 2006 Aug; 19(8):657-66. PubMed ID: 16827683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
    Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation.
    Charco R; Rimola A; García-Valdecasas JC; Fuster J; Fondevila C; Navasa M; Julian M; Forta V; Brunet M
    Transplant Proc; 2005 Nov; 37(9):3930-1. PubMed ID: 16386588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.
    Grevel J; Welsh MS; Kahan BD
    Ther Drug Monit; 1989; 11(3):246-8. PubMed ID: 2658210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase in renal vascular resistance after intake of cyclosporin A and tacrolimus and reversal by nitroglycerin spray: a study in patients with stable renal allograft function.
    Weingart C; Leingärtner T; Bergler T; Krüger B; Böger C; Mack M; Banas B; Krämer BK
    Int J Clin Pharmacol Ther; 2006 Sep; 44(9):422-7. PubMed ID: 16995330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
    Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
    Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C2 is an age-independent parameter for optimal cyclosporine exposure in long-term kidney transplant recipients.
    Ferraresso M; Citterio F; Ghio L; Romagnoli J; Edefonti A; Berardinelli L; Castagneto M
    Transplant Proc; 2004 Nov; 36(9):2656-8. PubMed ID: 15621115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
    Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB; Karamperis N; Jørgensen KA
    Transplant Proc; 2005 May; 37(4):1736-8. PubMed ID: 15919449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of the pharmacokinetics of cyclosporine in patients following long-term administration after a kidney transplant: comparison of Neoral and Sandimmune.
    Takahara S; Ichimaru N; Kojima Y; Namba Y; Toki K; Shi Y; Yoshimura K; Matsumiya K; Nonomura N; Okuyama A
    Transplant Proc; 2004 Mar; 36(2 Suppl):456S-460S. PubMed ID: 15041387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation.
    Aidong W; Zhenjie C; Tong L; Lei Z; Yin W; Shanqi Z; Liping T
    Transplant Proc; 2004 Oct; 36(8):2388-9. PubMed ID: 15561258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective.
    Villamil F; Pollard S
    Liver Transpl; 2004 May; 10(5):577-83. PubMed ID: 15108248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.